Amoeba, producer of a biological biocide, capable of eliminating bacterial risk in water and human wounds, and a biocontrol product for plant protection, listed on Euronext Growth, issued a new bonds facility.
This financing subscribed by Nice & Green, a company specialized in providing corporate services and flexible financing solutions to listed companies, has been structured by the issuance of a convertible bonds facility amounting to 23M€.
This new facility aims at pursuing the development of the Amoeba’s biocontrol application as well as restructuring Amoeba’s debt and consolidating its equity.
This new facility also provides for an incentive program allowing Amoeba to benefit from a part of the potential positive financial result of the transaction for Nice & Green.
Nice & Green has been advised by Solferino Associés (Fouad Bellaaroussi & Camille Chastagner).
Amoeba has been advised by Lamy Lexel (Vincent Medail & Aymeric Vuillermet).